Why is Mangalam Drugs falling/rising?

As of 28-Aug, Mangalam Drugs and Organics Ltd is experiencing a decline in its stock price, currently at Rs 74.08, which reflects a decrease of Rs 5.12 or 6.46%. The stock has been underperforming significantly, with a consecutive fall over the last four days, resulting in a total return of -7.62% in the past week. Today's trading saw the stock reach an intraday high of Rs 82.3 but also a low of Rs 72.62, indicating high volatility with a wide trading range of Rs 9.68. The stock is trading below all major moving averages and has seen a decrease in investor participation, with delivery volume falling by 1.89% against the five-day average. Additionally, the company's financial performance has been poor, with a return of -43.84% over the past year and a significant drop in profits by -399.4%, leading to concerns about its long-term fundamental strength.
In the broader market context, Mangalam Drugs has consistently underperformed against the benchmark, with a return of -7.62% over the past week compared to the Sensex's decline of only -2.34%. Over the last year, while the stock has plummeted by -43.84%, the Sensex has only decreased by -2.08%, highlighting the stock's significant weakness. The company's operating losses and declining net sales, which fell by -21.48%, further exacerbate its negative outlook. With a weak ability to service its debt and a low return on equity, the stock's performance is not only disappointing in isolation but also starkly contrasts with the broader market trends, reinforcing its status as a strong sell.